The Impact of Overactive Bladder on the Urology Practice: PHARMACOLOGICAL MANAGEMENT

The sNDA is supported by data from the pivotal phase 3 ARANOTE trial.

In this episode of Speaking of Urology, former MLB player Dave Winfield shares lessons he’s learned throughout his professional baseball career and his work in philanthropy.

Initial results on ADI-270 are anticipated for the first half of 2025.

In this episode, Robert E. Brannigan, MD, and Juan J. Andino, MD, MBA, discuss the recent amendment to the AUA/ASRM guideline on male infertility.

At the time of data cutoff, 71% of patients achieved a complete response following treatment.

The primary objective is to compare the detection rate of sites of prostate cancer recurrence between the 2 agents.